PCN176 Adding Bevacizumab To Single-Agent Chemotherapy For The Treatment Of Platinum-Resistant Recurrent Ovarian Cancer: A Cost-Effectiveness Analysis Of The Aurelia Trial
| Autor: | Schaffer, EM, Coles, TM, Wysham, WZ, Roque, DR, Kim, KH, Wheeler, SB |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Value in Health. (7):A461 |
| ISSN: | 1098-3015 |
| DOI: | 10.1016/j.jval.2015.09.1193 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|